首页 | 本学科首页   官方微博 | 高级检索  
     

鸦胆子油乳联合含铂类一线化疗方案治疗非小细胞肺癌的Meta分析
引用本文:王权,王满才,何曦冉,高天明,曹慧,窦文婕,田金徽. 鸦胆子油乳联合含铂类一线化疗方案治疗非小细胞肺癌的Meta分析[J]. 中国中药杂志, 2012, 37(13): 2022-2029
作者姓名:王权  王满才  何曦冉  高天明  曹慧  窦文婕  田金徽
作者单位:1. 兰州大学循证医学中心,甘肃兰州730000;兰州大学第一临床医学院,甘肃兰州730000
2. 兰州大学循证医学中心,甘肃兰州730000;兰州大学第二临床医学院,甘肃兰州730000
3. 兰州大学循证医学中心,甘肃兰州,730000
基金项目:国家大学生创新性实验项目(222000860213);中央高校基本科研业务费专项(lzujbky-2011-133)
摘    要:目的:该研究旨在评价鸦胆子油乳(brucea javanica oil emulsion,BJOE)联合含铂类一线化疗药物治疗非小细胞肺癌(non-small cell lung cancer,NSCLC)的疗效和安全性。方法:计算机检索Cochrane Library,PubMed,EMBASE,中国生物医学文献数据库,中国期刊全文数据库,中文科技期刊全文数据库,检索时间截止2011年2月,纳入有关鸦胆子油乳联合含铂类一线化疗药物治疗NSCLC的随机对照试验(randomized controlled trials,RCTs),由2名研究员分别独立提取数据和进行文献质量评价,并用RevMan5.1.2软件进行Meta分析。结果:共纳入22篇RCTs,共计病例数为1 512例。Meta分析结果显示,与单纯运用含铂类一线化疗方案相比,联合鸦胆子油乳能明显增加NSCLC患者化疗效果(RR=1.31,95%CI:1.18~1.45,P<0.000 01),提高生活质量(RR=1.78,95%CI:1.51~2.09,P<0.000 01),增强机体免疫力,降低骨髓抑制(OR=0.37,95%CI:0.27~0.51,P<0.000 01)和消化道毒副反应(OR=0.59,95%CI:0.44~0.80,P=0.000 7)。结论:鸦胆子油乳能提高非小细胞肺癌患者的化疗效果,改善生活质量,并降低含铂类化疗药物的毒副作用,值得临床借鉴。

关 键 词:鸦胆子  非小细胞肺癌  Meta分析
收稿时间:2011-10-03

Meta-analysis on treatment of non-small cell lung cancer with brucea javanica oil emulsion in combination with platinum-contained first-line chemotherapy
WANG Quan,WANG Mancai,HE Xiran,GAO Tianming,CAO Hui,DOU Wenjie and TIAN Jinhui. Meta-analysis on treatment of non-small cell lung cancer with brucea javanica oil emulsion in combination with platinum-contained first-line chemotherapy[J]. China Journal of Chinese Materia Medica, 2012, 37(13): 2022-2029
Authors:WANG Quan  WANG Mancai  HE Xiran  GAO Tianming  CAO Hui  DOU Wenjie  TIAN Jinhui
Affiliation:Evidence-Based Medicine Center of Lanzhou University, Lanzhou 730000, China;The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China;Evidence-Based Medicine Center of Lanzhou University, Lanzhou 730000, China;The Second Clinical Medical College of Lanzhou University, Lanzhou 730000, China;Evidence-Based Medicine Center of Lanzhou University, Lanzhou 730000, China;The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China;Evidence-Based Medicine Center of Lanzhou University, Lanzhou 730000, China;The Second Clinical Medical College of Lanzhou University, Lanzhou 730000, China;Evidence-Based Medicine Center of Lanzhou University, Lanzhou 730000, China;Evidence-Based Medicine Center of Lanzhou University, Lanzhou 730000, China;The Second Clinical Medical College of Lanzhou University, Lanzhou 730000, China;Evidence-Based Medicine Center of Lanzhou University, Lanzhou 730000, China
Abstract:Objective: To study the efficacy and safety of brucea javanica oil emulsion (BJOE) combining platinum-contained first-line chemotherapy in treating non small cell lung cancer (NSCLC). Method: Cochrane library,PubMed,EMBASE,VIP,CBM and CNKI were searched through computers. The search was finished in February,2011. Randomized controlled trials (RCTs) of BJOE combining platinum-contained first-line chemotherapy were included. Two researchers extracted data and assess literature quality separately,and made a meta-analyses by RevMan 5.1.2 software. Result: Totally 22 RCTs involving 1 512 patients were included. The Meta-analysis showed that compared with the pure application of platinum-contained first-line chemotherapy,the combination of BJOE and chemotherapy can enhance the near-term curative effect (RR=1.31,95% CI:1.18~1.45,P<0.000 01),improve the quality of life (RR=1.78,95%CI:1.51-2.09,P<0.000 01) and reduce the suppression of bone marrow (OR=0.37,95%CI:0.27-0.51,P<0.000 01) and the gastrointestinal reactions (OR=0.59,95%CI:0.44-0.80,P=0.000 7),with an improvement in organism immunity. Conclusion: The current evidence indicates that BJOE can enhance the chemotherapeutic effect on NSCLC patients,improve the quality of life and reduce adverse effect of platinum-contained chemotherapeutics and thus it is worth referring in clinic.
Keywords:brucea javanica oil emulsion  non-small cell lung cancer  Meta-analysis
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号